Skip to main content
PLOS Global Public Health logoLink to PLOS Global Public Health
. 2026 Mar 4;6(3):e0004659. doi: 10.1371/journal.pgph.0004659

Knowledge, attitudes and factors associated with the awareness of caregivers of under-five children regarding the malaria vaccine in the Tiko Health District, Cameroon: A community-based cross-sectional study

Maureen Abiache Idang 1, Divine Nsobinenyui 2, Chrisantus Eweh Ukah 3,*, Larissa Kumenyuy Yunika 3, Claudia Ngeha Ngu 3, Randolf Fuanghene Wefuan 3, Syveline Zuh Dang 3, Ndip Esther Ndip 3, Mirabelle Pandong Feguem 3, Claudine Mulih Shei 3, Dickson S Nsagha 3
Editor: Ruth Ashton4
PMCID: PMC12959648  PMID: 41779824

Abstract

Despite progress in malaria control, malaria remains a major public health burden in sub-Saharan Africa, particularly among children under five. The introduction of malaria vaccines, including RTS,S/AS01 (Mosquirix) and the recently WHO-recommended R21/Matrix-M, offers renewed hope for reducing malaria morbidity and mortality. The effectiveness of these vaccines, however, depends largely on caregivers’ awareness, knowledge, and attitudes. This study assessed caregivers’ knowledge and attitudes, and the factors associated with awareness of the malaria vaccine in the Tiko Health District of Cameroon. A community-based cross-sectional study was conducted among 410 caregivers of children aged 0–5 years who were selected using a multistage sampling technique. Data were collected using a structured pre-tested questionnaire. Descriptive statistics summarized participants’ characteristics, and knowledge and attitude scores were generated using a structured scoring system with a 60% cut-off defining adequate knowledge and positive attitudes. Logistic regression analysis identified factors independently associated with malaria vaccine awareness with statistical significance set at p < 0.05. The median age of participants was 32 years(IQR:27–40), and most were female(83.2%). Although 60.7% of caregivers had heard of the malaria vaccine, only 26.6% demonstrated adequate knowledge and 25.1% had positive attitudes. Healthcare workers were the primary source of vaccine information(35.4%). Caregivers whose children had a previous malaria episode were less likely to be aware of the vaccine(AOR:0.55; 95% CI:0.28–0.97). Conversely, caregivers who trusted health workers (AOR:3.02; 95% CI:1.83–4.99) and those who routinely attended childhood immunization services (AOR:3.57; 95% CI:2.27–5.60) were more likely to be aware of the vaccine. Caregivers in the Tiko Health District exhibited limited knowledge and generally negative attitudes toward the malaria vaccine. Strengthening health-worker engagement, improving communication during routine immunization services, and addressing gaps in caregivers’ understanding may enhance malaria vaccine uptake in the district.

Introduction

Malaria remains one of the most significant public health challenges globally, particularly in sub-Saharan Africa where it disproportionately affects vulnerable populations, including children under five years of age [14]. According to the World Health Organization (WHO), malaria accounted for an estimated 619,000 deaths in 2021, with young children representing a substantial proportion of these fatalities [5]. Despite ongoing efforts to control malaria through preventive measures such as insecticide-treated nets and antimalarial medications, the disease continues to pose a severe threat to child health in endemic regions [6,7].

The development of malaria vaccines has emerged as a promising strategy to complement existing prevention and treatment measures [8]. The RTS,S/AS01 (Mosquirix) vaccine, the first malaria vaccine to receive a WHO recommendation for use in children has shown efficacy in reducing malaria incidence and severe disease in clinical trials [912]. In Cameroon, the RTS,S/AS01 malaria vaccine was officially approved for introduction into the national Expanded Program on Immunization (EPI) in 2023 following the World Health Organization recommendation for its broader use [13]. Implementation of the malaria vaccine in Cameroon began in selected pilot health districts in late 2023, with gradual scale-up to additional districts in 2024 [14]. In the Tiko Health District, the malaria vaccine became available to eligible children through routine immunization services on January 22, 2024, prior to the conduct of this study [14]. This timing is important for interpreting caregivers’ awareness and knowledge, as exposure to malaria vaccine–related information in the district was still at an early phase during the period of data collection. However, the successful implementation of vaccination programs is contingent upon the awareness, knowledge, and attitudes of caregivers, who play a crucial role in the health-seeking behaviors of their children [1517].

In the Tiko health district, where malaria transmission is high understanding caregivers’ perceptions and knowledge about the malaria vaccine is essential for developing effective public health strategies [18]. Caregivers’ attitudes towards vaccination can significantly influence vaccine uptake and adherence, ultimately affecting the overall impact of vaccination campaigns. Factors such as cultural beliefs, previous experiences with healthcare services, and access to information can shape these attitudes and knowledge levels [19,20].

Research has indicated that misinformation and lack of awareness about vaccines can hinder vaccination efforts leading to lower coverage rates [21,22]. Moreover, caregivers’ socio-economic status, education level, and exposure to health education initiatives can further affect their understanding and acceptance of new interventions like the malaria vaccine [23]. Therefore, assessing caregivers’ knowledge and attitudes towards the malaria vaccine in the Tiko Health District is critical for identifying barriers to vaccination and informing tailored educational interventions.

This study aims to fill the gap in knowledge regarding caregivers’ perspectives on the malaria vaccine for under-five children in the Tiko health district. By exploring these dimensions, we hope to contribute valuable insights that can enhance vaccination strategies and ultimately reduce the burden of malaria among young children in this high-risk area.

This study was guided by the Health Belief Model (HBM), a widely used theoretical framework for understanding health-related decision-making and preventive behaviors. The HBM posits that individuals’ engagement in health actions is influenced by their perceived susceptibility to a disease, perceived severity of its consequences, perceived benefits of an intervention, perceived barriers to action, cues to action, and self-efficacy [24].

In the context of malaria vaccination, caregivers’ awareness, knowledge, and attitudes may be shaped by their perceptions of malaria risk to their children, beliefs about the effectiveness and safety of the vaccine, trust in health workers as cues to action, and prior experiences with malaria and routine immunization services [25,26]. By applying the HBM, this study conceptualizes caregivers’ awareness of the malaria vaccine as a function of both cognitive (knowledge and beliefs) and contextual factors (health system trust and vaccination practices).

Materials and methods

Research design

This study used a cross-sectional study design to assess the knowledge and attitudes of caregivers of children age 0-5 years in the Tiko Health District

Study area

The study was carried out in the Tiko Health District of the Southwest Region of Cameroon from 1st of March 2025 to the 11th of April 2025. Tiko Health District (THD), found in Fako Division, South West Region of Cameroon is located between latitude 9˚32'2"N to 9˚40'9"N and longitude 9˚25'7"E to 9˚55'7"E and an altitude of 32.84 m (107.76 ft). Tiko District, located in the Southwest Region of Cameroon, is divided into eight health areas. These health areas are managed by the local health administration and serve as the primary zones for delivering healthcare services to the community. Each health area typically includes a number of health centers and posts that provide essential services, such as maternal and childcare, immunization, treatment for infectious diseases like malaria, and other public health services.

Study settings and duration

This study was conducted from 1 March 2025 to 11 April 2025 in selected health areas of the Tiko Health District.. The six of the eight selected health areas were: Likomba, Holforth, Mutengene, Misselele, Tiko Town, and Kange.

Target topulation

The target population for this study was caregivers of children 0–5 years old resident within the Tiko Health District.

Sample size

The sample size was obtained using the formula for estimation of confidence interval for a proportion.

n=z2*P(1p)e2

Where;

Z= 1.96 (for 95% confidence level)

P= 0.5 (estimated proportion of caregivers’ awareness),

e= 0.05 (margin of error)

n=1.962*P(10.5)0.052=384. To compensate for possible non-response and enhance the precision of estimates, the minimum sample size of 384 was increased to 410 participants.

Sampling technique

This study employed a multi-stage sampling technique to assess the knowledge, attitudes, and factors associated with under-five awareness regarding the malaria vaccine within the Tiko health districts. The Tiko health districts comprise eight distinct health areas. To ensure a representative sample while maintaining feasibility, six of these health areas were randomly selected by balloting. This approach allowed for an unbiased selection process, ensuring that each health area had an equal opportunity to be included in the study. Following the selection of the health areas, community health workers were engaged to identify households with children under the age of five. These health workers possess intimate knowledge of their respective communities and were instrumental in locating eligible households. The identification process involved collaboration with community health workers who provided a list of households with under-five children within the selected health areas. A probability proportionate to size sampling was then used to determine the number of caregivers to be selected from each of the selected six health areas (Table 1)

Table 1. Number of caregivers selected per selected health area.

Health Area Estimated caregivers Population Proportion of caregivers Allocated Sample (n)
Holforth 5,706 0.28 113
Mutengene 8,170 0.40 162
Likomba 1,798 0.09 36
Misselele 955 0.05 19
Kange 709 0.03 14
Tiko Town 3,303 0.16 66
Total 20,641 1.00 410

Once the households were identified, caregivers of under-five children were approached for participation in the study. The selection of participants was based on their availability and willingness to participate, ensuring that informed consent was obtained prior to data collection. This systematic approach facilitated the recruitment of a diverse sample of caregivers, thereby enhancing the reliability and validity of the findings regarding their knowledge and attitudes, factors associated with their awareness regarding the malaria vaccine. The sampling technique utilized in this study involved a combination of random selection of health areas and purposeful identification of households by community health workers, which collectively contributed to a robust methodology for understanding caregiver perspectives in the Tiko health districts. Caregivers in identified households were recruited consecutively until the until the determined sample size per health area was reached.

Inclusion criteria

Caregivers of under-five children living in the Tiko health district who gave their consent were included in the study.

Exclusion criteria

Under-five children’s caregivers who were severely ill at the time of data collection.

Data collection tools and methods

Data collection for this study was conducted using a pre-tested structured questionnaire designed to gather comprehensive information on the knowledge and attitudes of caregivers of under-five children toward the malaria vaccine. The questionnaire was pre-test among 20 caregivers in the Buea Health District which was not part of the study area. The questionnaire was systematically divided into three distinct sections to facilitate focused data collection:

Section A: Socio-demographic variables

This section collected essential demographic information, including age, level of education, religion, location, and marital status of the caregivers. These variables provide context for understanding the background of participants and their potential influence on knowledge and attitudes toward the malaria vaccine.

Section B: Knowledge of caregivers

This section assessed the knowledge of caregivers regarding the malaria vaccine through ten closed-ended questions. These questions were designed to evaluate caregivers' understanding of malaria, its transmission, prevention strategies, and specific details about the malaria vaccine.

Section C: Attitudes toward the malaria vaccine

This section focused on the attitudes of caregivers toward the malaria vaccine, comprising ten closed-ended questions. The questions aimed to capture caregivers' perceptions, beliefs, and feelings about the vaccine, including any concerns or misconceptions they may have.

To ensure the validity and reliability of the questionnaire, a pre-test was conducted among ten under-five children in the Buea Health District at the Tole Health Area. This pre-test allowed for adjustments to be made to improve clarity and applicability during data collection.

Conceptual framework: Health Belief Model (HBM)

The study was guided by the Health Belief Model (HBM), which is commonly used to explain and predict health-related behaviors, including vaccine acceptance. The HBM posits that individuals’ decisions to adopt a health behavior are influenced by six key constructs:

  1. Perceived susceptibility – caregivers’ beliefs about their child’s likelihood of contracting malaria.

  2. Perceived severity – beliefs regarding the seriousness of malaria and its consequences.

  3. Perceived benefits – caregivers’ beliefs about the effectiveness of the malaria vaccine in preventing malaria.

  4. Perceived barriers – concerns about vaccine safety, side effects, or misinformation that may prevent vaccination.

  5. Cues to action – triggers such as advice from health workers, community messages, or prior child illness that motivate caregivers to seek vaccination.

  6. Self-efficacy – caregivers’ confidence in their ability to access vaccination services for their children.

The questionnaire was developed to incorporate these constructs, and variables included in the analysis were mapped onto the HBM components. The model also informed the interpretation of factors associated with caregivers’ awareness of the malaria vaccine.

Data collection

Data collection was carried out by the principal investigator and four trained research assistants using the structured questionnaires. The process involved both self-administration for caregivers who were literate and interviewer administration for those who required assistance. For literate participants, the questionnaires were self-administered; for those who were unable to read or write, the research assistants read the questions aloud and recorded their responses.

Prior to participation, all caregivers were adequately informed about the study through a written information sheet and detailed verbal explanations. Written informed consent was obtained from each participant before proceeding with data collection. Participants were made aware of their rights to withdraw from the study at any time without any repercussions. Confidentiality was strictly maintained by anonymizing responses; no names were recorded on the questionnaires. Instead, each questionnaire was assigned a unique file number, accessible only to the investigator for data analysis purposes.

The research assistants underwent a comprehensive training program that included a detailed training agenda and manual. Training covered essential topics such as data collection techniques, community engagement strategies, ethical considerations, and maintaining confidentiality throughout the study process. This training ensured that all research assistants were well-prepared to conduct data collection effectively and ethically.

Ethical considerations

Ethical clearance was obtained from the Ethics Committee for Human Health Research in the Southwest Region of Buea. Additionally, administrative authorizations were secured from the Faculty of Health Sciences Institutional Review Board at the University of Douala, which were subsequently submitted to the Tiko District Health Services prior to data collection.

Informed consent was obtained from all participants prior to their inclusion in the study. Participants were provided with a detailed consent form that outlined the purpose of the research, the procedures involved, potential risks and benefits, and their right to withdraw from the study at any time without any consequences. This ensured that participants had a clear understanding of their involvement and could make an informed decision regarding their participation.

Confidentiality was strictly maintained throughout the research process. All data collected were anonymized, and identifying information was removed to protect participants’ privacy. Data were stored securely and accessible only to authorized research personnel. Findings were reported in aggregate form, ensuring that individual responses could not be traced back to any participant. These measures were implemented to foster trust and ensure that participants felt safe and secure while contributing to the research.

Data management and data analysis

Data management and analysis followed a systematic approach to ensure accuracy and reliability. Upon collection, questionnaires were thoroughly checked for completeness. Any incomplete questionnaires were discarded to maintain the integrity of the data.

The completed questionnaires were securely stored in a locked cupboard, accessible only to the principal investigator, until the data collection process was finalized. Once data collection was complete, an Excel spreadsheet generated from Kobo Toolbox was imported into SPSS version 26 for analysis. Additionally, a soft copy of the spreadsheet was saved on a flash drive and sent via email for backup purposes.

Data were analyzed using the Statistical Package for the Social Sciences (SPSS), version 26, with results presented in tables and charts. Continuous variables, such as age, were described using summary statistics, including means and standard deviations. Categorical variables, such as educational level and marital status, were summarized using frequency tables.

To assess caregivers’ knowledge, toward the malaria vaccine, a scoring system was implemented. Each of the knowledge and attitudes sections of the questionnaire contained seven questions, with a maximum obtainable score of 7 for knowledge and 21 for attitudes.. For knowledge, correct answers received a score of one (1), while incorrect answers received zero (0). The total score for each participant was calculated based on their responses. A 60% cut-off point was used to classify adequate knowledge and positive attitudes, consistent with thresholds commonly applied in KAP (Knowledge, Attitudes, and Practices) studies. The 60% of the maximum obtainable score across all participants for each section was determined; those scoring at or above the 60% score were classified as having good knowledge, or positive attitudes while those scoring below the average were classified as having poor knowledge, or negative attitudes.

The anonymized dataset used for this study is provided in the supporting information (S1 Data).

Results

Socio-demographic characteristics

The mean age of the 410 caregivers was 33.6 and the standard deviation was 8.9. A total of 219 (53.4%) of caregivers were within the age group 21–35 years and 341 (83.2%) of them were females. Secondary education was the dominant educational level 160 (39.0%) and 340 (82.9%) were Christians. A majority 249 (60.7%) were married and 158 (38.5%) were self-employed. A vast majority 329 (80.2%) of the caregivers were direct parents of the under-five children and 391 (95.4%) were non-smokers (Table 2)

Table 2. Socio-demographic characteristics of caregivers (n = 410).

Variable Category Frequency Percentage
Age group (years) <21 20 4.8
21-35 219 53.4
36-50 149 36.3
51-65 22 5.4
Sex Male 69 16.8
Female 341 83.2
Education No formal 71 17.3
Primary 81 19.8
Secondary 160 39.0
Tertiary 98 23.9
Religion Muslim 70 17.1
Christian 340 82.9
Marital status Single 134 32.7
Married 249 60.7
Widowed 23 5.6
Divorced 4 1.0
Employment status Student 49 12.0
Unemployed 83 20.2
Self-employed 158 38.5
Employed 120 29.3
Relation with child Not related 22 5.4
Other relative 36 8.8
Parents 329 80.2
Sibling 23 5.6
Number of children 1-2 236 57.6
3-4 131 32.0
>4 43 10.5
Household income (XAF, [1USD = 550.76XAF]) <50000 138 33.7
51000-100000 206 50.2
>100000 66 16.1
Smoking status Smoke 19 4.6
Not smoke 391 95.4
Alcohol consumption No 127 31.0
Yes 283 69.0
Accessible health services No 64 15.6
Yes 346 84.4
Child ever had malaria before No 61 14.9
Yes 349 85.1
Trust health workers No 95 23.2
Yes 315 76.8
Go for general routine vaccination No 136 33.2
Yes 274 66.8

Knowledge of caregivers of under five children on the malaria vaccine in the Tiko Health District

Regarding the knowledge of caregivers on the malaria vaccine (Table 3), 145 (35.4%) sources of information on the vaccine was healthcare worker and 249 (60.7%) were aware of the existence of the malaria vaccine. Of the 249 who were aware of the existence of the malaria vaccine, 145 (58.2%) did not know that the vaccine was approved in Cameroon and 109 (43.8%) knew that the purpose of the malaria vaccine was to boost immunity in order to prevent the malaria infection. Note: Because the study population included children aged 0–5 years, not all children were old enough to receive all four RTS,S vaccine doses. To avoid misclassification, we considered age-eligibility for each dose when interpreting the ‘vaccine doses taken’ variable. Children who had not yet reached the recommended age for Dose 2, Dose 3, or Dose 4 were classified as ‘not yet age-eligible’ rather than ‘unvaccinated’. The categories ‘1 dose’, ‘2 doses’, ‘3 doses’, and ‘4 doses’ therefore represent only children who were age-eligible for those doses at the time of data collection.

Table 3. Knowledge of under-five caregivers on the malaria vaccine in the Tiko Health District (n = 410).

Variable Category Frequency Percentage
Source of information Family and friends 65 15.9
Health care provider 145 35.4
None 140 34.1
Others 4 1.0
Social media 56 13.7
Aware of malaria vaccine No 161 39.3
Yes 249 60.7
Know that malaria vaccine is approved in Cameroon No 145 58.2
Yes 104 41.8
Purpose of the malaria vaccine I do not know 10 4.0
To boost the child immune. 63 25.3
To prevent malaria infections. 109 43.8
To reduce fever associated with malaria 27 10.8
To treat malaria symptoms. 40 16.1
Doses of malaria vaccine





Required age to start vaccinating children against malaria
1 dose 59 23.6
2 doses 64 25.7
3 doses 55 22.1
4 doses 30 12.0
I do not know 41 16.5
At 1 year 53 21.2
At 3 months 49 19.7
At 6 months 75 30.1
At birth 33 13.3
I do not know 39 15.7
Malaria vaccine is 100% effective


What you do when your child misses a vaccine dose/schedule
False 165 66.3
True 84 33.7
Consult a healthcare provider for advice 89 35.7
Skip that dose and continue with the next one. 42 16.9
Start the vaccination schedule again from the beginning 79 31.7
Wait until the next schedule dose 39 15.7

1Dose counts represent only children who were age-eligible for each respective RTS,S malaria vaccine dose at the time of data collection. Children who had not yet reached the recommended age for Dose 2, Dose 3, or Dose 4 were classified as ‘not yet age-eligible’ rather than ‘unvaccinated.

Regarding caregivers’ knowledge of the side effects of the malaria vaccine, 74 (31.8%) reported not knowing any side effect (Fig 1).

Fig 1. Distribution of caregivers according to their knowledge of the side effects of the malaria vaccine.

Fig 1

With respect to the overall knowledge of caregivers on the malaria vaccine, 60% of the maximum obtainable score was used as the cut off point for good knowledge, the overall good knowledge of the malaria vaccine was 26.6%.

Attitudes of under-five caregivers toward the malaria vaccine in the Tiko Health District

Regarding the attitudes of caregivers toward the malaria vaccine (Table 4), 249 (60.7%) agreed that, vaccinating their children against malaria was crucial and 235 (57.3%) agreed that malaria vaccine was a safe option for protecting their children from malaria. A total of 219 (53.4) agreed that they trust the information provided by healthcare workers on the malaria vaccine and 169 (41.2%) agreed that completing the full course of the vaccine was essential for ensuring its effectiveness.

Table 4. Attitudes of under-five caregivers toward the malaria vaccine.

Variable Strongly disagree Disagree Agree Strongly agree
I believe that vaccinating my child against malaria is crucial for their health 21(5.1) 68(16.6) 249(60.7) 72(17.6)
Malaria vaccine is a safe option for protecting my child from malaria. 100(24.4) 54(13.2) 235(57.3) 21(5.1)
Trust the information provided by healthcare professionals. 24(5.9) 137(33.4) 219(53.4) 30(7.3)
Completing the full course of malaria vaccination is essential for ensuring its effectiveness. 130(31.7) 67(16.3) 169(41.2) 44(10.7)
Believe that the benefits of the malaria vaccine outweigh any potential risks 134(32.7) 78(19.0) 166(40.5) 32(7.8)
My child should receive the malaria vaccine according to the recommended vaccination schedule.ended vaccination schedule 126(30.7) 81(19.8) 161(39.3) 42(10.2)
I believe that the malaria vaccine is an important tool in preventing malaria related illnesses in children. 33(8.0) 174(42.4) 174(42.4) 29(7.1)
Overall attitudes Positive = 103 (25.1%)
Negative = 307 (74.9%)

For the overall attitudes of caregivers toward the malaria vaccine (Table 4), a total of seven questions were asked with the options ranging from strongly disagree (0) to strongly agree (3). The maximum obtainable score was 21. A 60% cutoff point was used for overall positive attitudes. Those who scored 13 out of the 21 maximum obtainable score were classified as having overall positive attitudes and those who scored below 13 as having overall negative attitudes. Following this, 103 (25.1%) had overall positive attitudes toward the malaria vaccine.

Factors associated with awareness of the malaria vaccine among caregivers of children 0–5 years

At the level of the bivariable analysis using simple logistic regression with unadjusted/crude odd ratios (COR), four factors were found significantly associated with malaria vaccine awareness among caregivers of children 0–5 years. Factors with a p value of <0.2 were taken to the multivariable analysis to identify factors independently associated with malaria vaccine awareness using multiple logistic regression with adjusted odd rations.

Factors found significantly associated in the bivariable analysis were sex of caregiver, smoking status, trust in health workers, and going for general routine vaccination (Table 5).

Table 5. Factors associated with awareness of the malaria vaccine using simple logistic regression.

Aware of malaria vaccine 95% CI for COR
Variable Category No Yes COR Lower Upper p value
Sex Female 124(30.2) 217(52.9) 2.02 1.20 3.41 0.008
Male 37(9) 32(7.8) 1
Education Tertiary 30(7.3) 68(16.6) 1.48 0.78 2.80 0.234
Secondary 63(15.4) 97(23.7) 1.00 0.57 1.78 0.993
Primary 40(9.8) 41(10) 0.67 0.35 1.27 0.219
No formal 28(6.8) 43(10.5) 1
Religion Muslim 129(31.5) 211(51.5) 1.38 0.82 2.31 0.226
Christian 32(7.8) 38(9.3) 1
Marital status Widowed 2(0.5) 2(0.5) 0.76 0.10 5.58 0.790
Divorced 9(2.2) 14(3.4) 1.19 0.48 2.93 0.710
Married 92(22.4) 157(38.3) 1.30 0.85 2.00 0.226
Single 58(14.1) 76(18.5) 1
Health related work/field of study Yes 10(2.4) 23(5.6) 1.54 0.71 3.32 0.274
No 151(36.8) 226(55.1) 1
Relationship with child Siblings 11(2.7) 12(2.9) 1.09 0.34 3.51 0.884
Parents 124(30.2) 205(50) 1.65 0.70 3.93 0.255
Others 15(3.7) 21(5.1) 1.40 0.48 4.07 0.536
No direct relation 11(2.7) 11(2.7) 1
Smoking status Smoker 149(36.3) 242(59) 2.78 1.07 7.23 0.035
Non-smoker 12(2.9) 7(1.7) 1
Alcohol consumption Yes 114(27.8) 169(41.2) 0.87 0.57 1.34 0.530
No 47(11.5) 80(19.5) 1
Accessible health services Yes 130(31.7) 216(52.7) 1.56 0.91 2.67 0.104
No 31(7.6) 33(8) 1
Child has previous malaria infection Yes 144(35.1) 205(50) 0.55 0.30 1.00 0.050
No 17(4.1) 44(10.7) 1
Trust health workers Yes 103(25.1) 212(51.7) 3.23 2.01 5.19 <0.001
No 58(14.1) 37(9) 1
Go for general routine vaccination Yes 80(19.5) 194(47.3) 3.57 2.32 5.49 <0.001
No 81(19.8) 55(13.4) 1

COR: Crude Odd Ratio, CI: Confidence Interval

After adjusting for potential confounders in the multivariable logistic regression model, three factors remained independently associated with caregivers’ awareness of the malaria vaccine (Table 6). Caregivers whose children had previously experienced malaria were significantly less likely to be aware of the malaria vaccine compared with those whose children had no prior malaria history (Adjusted Odds Ratio [AOR] = 0.55; 95% Confidence Interval [CI]: 0.28–0.97; p = 0.040).

Table 6. Factors independently associated with the malaria vaccine awareness among caregivers.

Aware of malaria vaccine 95% CI for COR
Variable Category No Yes AOR Lower Upper p value
Religion Muslim 129(31.5) 211(51.5) 1.44 0.79 2.64 0.237
Christian 32(7.8) 38(9.3) 1
Smoking status Smoker 149(36.3) 242(59) 1.96 0.69 5.54 0.204
Non-smoker 12(2.9) 7(1.7) 1
Alcohol consumption Yes 114(27.8) 169(41.2) 0.73 0.44 1.20 0.21
No 47(11.5) 80(19.5) 1
Child has previous malaria infection Yes 144(35.1) 205(50) 0.55 0.28 0.97 0.040
No 17(4.1) 44(10.7) 1
Trust health workers Yes 103(25.1) 212(51.7) 3.02 1.83 4.99 <0.001
No 58(14.1) 37(9) 1
Go for general routine vaccination Yes 80(19.5) 194(47.3) 3.57 2.27 5.60 <0.001
No 81(19.8) 55(13.4) 1

Abbreviations: COR, Crude Odds Ratio; AOR, Adjusted Odds Ratio; CI, Confidence Interval.

Model statistics: Number of observations = 410; Pseudo R2 = 0.299; Hosmer–Lemeshow goodness-of-fit test p = 0.670.

In contrast, caregivers who reported trusting health workers were significantly more likely to be aware of the malaria vaccine than those who did not trust health workers (AOR = 3.02; 95% CI: 1.83–4.99; p < 0.001). Similarly, caregivers who routinely took their children for general childhood immunization were more likely to be aware of the malaria vaccine compared with those who did not attend routine immunization services (AOR = 3.57; 95% CI: 2.27–5.60; p < 0.001).

The multivariable logistic regression model demonstrated adequate fit to the data (Hosmer–Lemeshow p = 0.670) and explained approximately 29.9% of the variance in caregivers’ awareness of the malaria vaccine (Pseudo R2 = 0.299).

Discussion

This study assessed caregivers’ knowledge, attitudes, and factors associated with awareness of the malaria vaccine among caregivers of children under five years of age in the Tiko Health District, Cameroon. Overall, the findings reveal low levels of both knowledge and positive attitudes toward the malaria vaccine, despite moderate awareness of its existence. Guided by the Health Belief Model (HBM), these findings highlight important cognitive and contextual determinants of malaria vaccine awareness that are relevant for public health programming.

Only 26.6% of caregivers demonstrated good overall knowledge about the malaria vaccine. Although 60.7% of respondents had heard about the vaccine, deeper understanding was limited. A significant proportion of those aware of the vaccine did not know it had been approved in Cameroon, and many had misconceptions about its purpose. This low knowledge level is concerning as studies have shown that, misconception as a result of inadequate knowledge is negatively associated with the malaria vaccine uptake [27,28].Within the HBM framework, inadequate knowledge may reduce perceived benefits of vaccination and increase perceived barriers, thereby undermining caregivers’ readiness to engage in preventive behaviors [26]. This is consistent with previous studies conducted in various regions of sub-Saharan Africa like the one in Nigeria and Tanzania [29,30], which often report low levels of knowledge among caregivers regarding malaria vaccination. For instance, a study conducted in Tanzania in 2025 reported 14.7% awareness of caregivers on the malaria vaccine [27]. Another study in Nigeria also reported a 30% awareness of the malaria vaccine reported in Northern Nigeria [31]. Although some studies reported slightly higher awareness levels (around 30–40%), these differences are modest and may reflect contextual variations rather than major epidemiological differences [32].

Attitudinal assessment revealed that only 25.1% of caregivers had a positive attitude toward the malaria vaccine. Although a majority (60.7%) agreed that vaccinating children is crucial, concerns about safety, efficacy, and mistrust of health information remain high. Less than half of caregivers agreed that completing the full vaccine course is essential, and over 30% expressed skepticism about the vaccine’s safety. From an HBM perspective, these concerns reflect high perceived barriers and insufficient perceived benefits, which may explain the observed gap between general support for vaccination and willingness to fully embrace the malaria vaccine [26].

These findings mirror results from Tanzania, where caregivers expressed concerns about vaccine side effects and effectiveness, which led to vaccine hesitancy [33]. Similarly, in Uganda, positive attitudes were reported only when caregivers had received direct counseling and community engagement interventions [34]. The relatively low trust in information from health professionals in our study (53.4% agreeing or strongly agreeing) further highlights the need for improved communication strategies that foster trust and transparency.

The low proportion of caregivers who exhibited both good knowledge and positive attitudes is particularly troubling. It suggests that many caregivers, even if aware of the vaccine, may remain hesitant due to unresolved doubts or misinformation. This disconnects between awareness and confidence can undermine vaccine rollout efforts and delay progress in malaria control.

In this study, we identified key factors associated with under-five caregivers’ awareness of the malaria vaccine. Caregivers whose children had previously experienced malaria were less likely to be aware of the malaria vaccine. This finding may reflect a reliance on curative care following malaria episodes, with less attention given to preventive strategies. Within the HBM framework, prior malaria experience may heighten perceived severity but does not necessarily translate into increased perceived benefits of vaccination, particularly in the absence of effective counseling during treatment encounters [26]. This finding may reflect a perception among affected caregivers that treatment is the primary recourse, thereby reducing attention to preventive measures such as vaccination [35]. It could also suggest missed opportunities for health education during malaria treatment encounters, where health personnel could leverage the moment to introduce and promote the malaria vaccine.

Consistent with the HBM, trust in health workers emerged as a strong positive predictor of caregivers’ awareness of the malaria vaccine. Trust in healthcare providers likely functions as a key cue to action, facilitating the acceptance of new health information and innovations. Caregivers who expressed trust in health professionals were more likely to be aware of the malaria vaccine than those who did not. This underscores the critical role of trust in health communication and uptake of health innovations. It suggests that enhancing the credibility and approachability of health workers may significantly improve public receptiveness to new health interventions, including vaccines [36].

Furthermore, participation in routine childhood immunization was strongly associated with awareness of the malaria vaccine. Caregivers who took their children for general vaccination were significantly more likely to be aware of the malaria vaccine than those who did not. This likely reflects greater engagement with the health system, increased exposure to health promotion messages, and habitual preventive health-seeking behaviors among these caregivers. These findings are similar to what was reported by a study in Northern Nigeria where prior infection of malaria and prior experience with vaccination were significantly associated with the malaria vaccine awareness [37].

Together, these findings highlight the importance of integrating malaria vaccine awareness into routine health service touchpoints, particularly childhood immunization programs, and underscore the need to build and maintain trust between communities and health providers. Tailored health education strategies targeting caregivers of children with prior malaria episodes may also be necessary to close the awareness gap and maximize uptake of the malaria vaccine.Top of FormBottom of Form.

These results highlight the need for intensified community sensitization efforts and caregiver-focused health education campaigns. Interventions should not only provide factual information about the vaccine but also address cultural beliefs, fears, and misinformation.

Training healthcare workers in interpersonal communication and community engagement is also essential. Given that health personnel are the most trusted sources of information, enhancing their capacity to deliver clear, empathetic, and persuasive vaccine messages could significantly influence caregiver perceptions and behaviors.

Strengths and limitations

A key strength of this study is its community-based approach, which allowed for the inclusion of a diverse and representative sample of caregivers of under-five children across the Tiko Health District. The use of trained research assistants and a standardized structured questionnaire helped ensure consistency in data collection and minimized interviewer bias. Additionally, the study addresses an important gap in the literature on malaria vaccine awareness in a real-world setting, providing timely and relevant evidence to inform public health interventions in Cameroon.

However, the study has some limitations. Its cross-sectional design limits the ability to infer causality between the identified factors and caregivers’ awareness of the malaria vaccine. Self-reported data may also be subject to recall and social desirability bias, particularly for sensitive topics such as trust in health workers or participation in vaccination programs. Also, while our overall sample size was adequate and determined using standard methods, we acknowledge that the number of events per predictor variable (EPV) in the multivariable model may have been limited for certain covariates.

Conclusion

In conclusion, this study reveals low levels of both knowledge and positive attitudes toward the malaria vaccine among caregivers of under-five children in the Tiko Health District. These gaps pose a significant barrier to successful vaccine implementation and require urgent, targeted interventions. Strengthening community health education, improving trust in health systems, and engaging caregivers directly will be crucial in enhancing the acceptance and uptake of the malaria vaccine in this high-risk population. Factors found associated with caregivers’ awareness of the malaria vaccine were trust in health workers, going for general child routine vaccination and history of malaria infection in the child.

Supporting information

S1 Data. Anonymized dataset used in the study.

(XLSX)

pgph.0004659.s001.xlsx (79KB, xlsx)

Data Availability

All relevant data are within the paper and its Supporting Information files. The de-identified dataset underlying the findings of this study has been provided as a Supporting Information file in Excel format.

Funding Statement

The authors received no specific funding for this work.

References

  • 1.Palombi L, Moramarco S. Health in sub-Saharan Africa: HIV, TB and malaria epidemiology. Multidisciplinary Teleconsultation in Developing Countries. 2018. p. 3–16. [Google Scholar]
  • 2.Oladipo HJ, Tajudeen YA, Oladunjoye IO, Yusuff SI, Yusuf RO, Oluwaseyi EM, et al. Increasing challenges of malaria control in sub-Saharan Africa: Priorities for public health research and policymakers. Ann Med Surg (Lond). 2022;81:104366. doi: 10.1016/j.amsu.2022.104366 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Kolawole E, Ayeni E, Abolade S, Ugwu S, Awoyinka T, Ofeh A, et al. Malaria endemicity in Sub-Saharan Africa: Past and present issues in public health. Microb Infect Dis. 2022. doi: 10.21608/mid.2022.150194.1346 [DOI] [Google Scholar]
  • 4.Mbishi JV, Chombo S, Luoga P, Omary HJ, Paulo HA, Andrew J, et al. Malaria in under-five children: prevalence and multi-factor analysis of high-risk African countries. BMC Public Health. 2024;24(1):1687. doi: 10.1186/s12889-024-19206-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Baraka V, Nhama A, Aide P, Bassat Q, David A, Gesase S, et al. Prescription patterns and compliance with World Health Organization recommendations for the management of uncomplicated and severe malaria: A prospective, real-world study in sub-Saharan Africa. Malar J. 2023;22(1):215. doi: 10.1186/s12936-023-04650-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Al-Worafi YM. Malaria management in developing countries. In: Handbook of medical and health sciences in developing countries: education, practice, and research. Springer; 2024. p. 1–40. [Google Scholar]
  • 7.Ehiri JE, Anyanwu EC, Scarlett H. Mass use of insecticide-treated bednets in malaria endemic poor countries: public health concerns and remedies. J Public Health Policy. 2004;25(1):9–22. doi: 10.1057/palgrave.jphp.3190001 [DOI] [PubMed] [Google Scholar]
  • 8.Birkett AJ, Moorthy VS, Loucq C, Chitnis CE, Kaslow DC. Malaria vaccine R&D in the Decade of Vaccines: breakthroughs, challenges and opportunities. Vaccine. 2013;31 Suppl 2:B233-43. doi: 10.1016/j.vaccine.2013.02.040 [DOI] [PubMed] [Google Scholar]
  • 9.Nadeem AY, Shehzad A, Islam SU, Al-Suhaimi EA, Lee YS. Mosquirix™ RTS, S/AS01 Vaccine Development, Immunogenicity, and Efficacy. Vaccines (Basel). 2022;10(5):713. doi: 10.3390/vaccines10050713 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Guerra Mendoza Y, Garric E, Leach A, Lievens M, Ofori-Anyinam O, Pirçon J-Y, et al. Safety profile of the RTS,S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa. Hum Vaccin Immunother. 2019;15(10):2386–98. doi: 10.1080/21645515.2019.1586040 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Sahoo JP, Mishra P, Sahoo S, Samal KC. Historic moment: WHO approves the world’s first malaria vaccine “Mosquirix or RTS, S/AS01”. Biotica Res Today. 2021;3(10):892–6. [Google Scholar]
  • 12.Arora N, Anbalagan C, Pannu AK. Towards eradication of malaria: is the WHO’s RTS, S/AS01 vaccination effective enough? Risk Manag Healthc Policy. 2021;1033–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Parums DV. Editorial: Current Status of Two Adjuvanted Malaria Vaccines and the World Health Organization (WHO) Strategy to Eradicate Malaria by 2030. Med Sci Monit. 2023;29:e939357. doi: 10.12659/MSM.939357 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Mboussou F, Ndoula ST, Nembot R, Baonga SF, Njinkeu A, Njoh AA, et al. Setting up a data system for monitoring malaria vaccine introduction readiness and uptake in 42 health districts in Cameroon. BMJ Glob Health. 2024;9(4):e015312. doi: 10.1136/bmjgh-2024-015312 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Mishra K, Mohapatra I, Kumar A. A study on the health seeking behavior among caregivers of under-five children in an urban slum of Bhubaneswar, Odisha. J Family Med Prim Care. 2019;8(2):498–503. doi: 10.4103/jfmpc.jfmpc_437_18 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Kalita D, Borah M, Kakati R, Borah H. Primary caregivers health seeking behaviour for under-five children: a study in a rural block of Assam, India. Ntl J Community Med. 2016;7(11):868–72. [Google Scholar]
  • 17.Abegaz NT, Berhe H, Gebretekle GB. Mothers/caregivers healthcare seeking behavior towards childhood illness in selected health centers in Addis Ababa, Ethiopia: a facility-based cross-sectional study. BMC Pediatr. 2019;19(1):220. doi: 10.1186/s12887-019-1588-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Bongajum JV, Babila NR, Eyong EM. Situational Analysis of Malaria Control Following the 2021 Distribution of Long Lasting Insecticide-Treated Bed Nets in the Tiko Health District, South West Region, Cameroon. JBM. 2023;11(04):153–72. doi: 10.4236/jbm.2023.114011 [DOI] [Google Scholar]
  • 19.Maamor NH, Muhamad NA, Mohd Dali NS, Leman FN, Rosli IA, Tengku Bahrudin Shah TPN, et al. Prevalence of caregiver hesitancy for vaccinations in children and its associated factors: A systematic review and meta-analysis. PLoS One. 2024;19(10):e0302379. doi: 10.1371/journal.pone.0302379 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Hutchinson AF, Smith SM. Effectiveness of strategies to increase uptake of pertussis vaccination by new parents and family caregivers: A systematic review. Midwifery. 2020;87:102734. doi: 10.1016/j.midw.2020.102734 [DOI] [PubMed] [Google Scholar]
  • 21.Peters MDJ. Addressing vaccine hesitancy and resistance for COVID-19 vaccines. Int J Nurs Stud. 2022;131:104241. doi: 10.1016/j.ijnurstu.2022.104241 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Zhang Y, Fisk RJ. Barriers to vaccination for coronavirus disease 2019 (COVID-19) control: experience from the United States. Glob Health J. 2021;5(1):51–5. doi: 10.1016/j.glohj.2021.02.005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Ntihebuwayo E, Nimpagaritse M, Bizimana T, Banzimana S, Kabura D, Sinarinzi P, et al. Acceptance of a malaria vaccine among caregivers of sick children under 5 years of age in Burundi. Malar J. 2025;24(1):90. doi: 10.1186/s12936-025-05327-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Rosenstock IM. Historical Origins of the Health Belief Model. Health Educ Monogr. 1974;2(4):328–35. doi: 10.1177/109019817400200403 [DOI] [PubMed] [Google Scholar]
  • 25.Rosenstock IM, Strecher VJ, Becker MH. Social learning theory and the Health Belief Model. Health Educ Q. 1988;15(2):175–83. doi: 10.1177/109019818801500203 [DOI] [PubMed] [Google Scholar]
  • 26.Glanz K, Rimer BK, Viswanath K. Health behavior: Theory, research, and practice. John Wiley & Sons; 2015. [Google Scholar]
  • 27.Bam V, Mohammed A, Kusi-Amponsah A, Armah J, Lomotey AY, Budu HI, et al. Caregivers’ perception and acceptance of malaria vaccine for Children. PLoS One. 2023;18(7):e0288686. doi: 10.1371/journal.pone.0288686 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Kimbi HK, Nkesa SB, Ndamukong-Nyanga JL, Sumbele IU, Atashili J, Atanga MB. Knowledge and perceptions towards malaria prevention among vulnerable groups in the Buea Health District, Cameroon. BMC Public Health. 2014;14:1–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Emmanuel BN, Ishaq AN, Akunne OZ, Saidu UF. Evaluating the knowledge, attitude, perception, and readiness of caregivers of under 5-year-old children to accept malaria vaccine in Nigeria. Clin Exp Vaccine Res. 2024;13(2):121–31. doi: 10.7774/cevr.2024.13.2.121 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Mwingira F, Matiya D, Chacky F. Knowledge and willingness towards malaria vaccines among caregivers in Dar es Salaam, Tanzania. Malar J. 2025;24(1):35. doi: 10.1186/s12936-024-05183-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Musa-Booth TO, Enobun BE, Agbomola AJ, Shiff CJ. Knowledge, attitude and willingness to accept the RTS, S malaria vaccine among mothers in Abuja Nigeria. medRxiv. 2020;2020. [Google Scholar]
  • 32.Ajayi MY, Emeto DC. Awareness and acceptability of malaria vaccine among caregivers of under-5 children in Northern Nigeria. Malar J. 2023;22(1):329. doi: 10.1186/s12936-023-04768-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Vasudevan L, Baumgartner JN, Moses S, Ngadaya E, Mfinanga SG, Ostermann J. Parental concerns and uptake of childhood vaccines in rural Tanzania - a mixed methods study. BMC Public Health. 2020;20(1):1573. doi: 10.1186/s12889-020-09598-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Nalwadda C, Tusubira AK, Nambuya H, Namazzi G, Muwanguzi D, Waiswa P, et al. Transition from hospital to home care for preterm babies: A qualitative study of the experiences of caregivers in Uganda. PLOS Glob Public Health. 2023;3(5):e0000528. doi: 10.1371/journal.pgph.0000528 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35.Bam V, Mohammed A, Kusi-Amponsah A, Armah J, Lomotey AY, Budu HI, et al. Caregivers’ perception and acceptance of malaria vaccine for Children. PLoS One. 2023;18(7):e0288686. doi: 10.1371/journal.pone.0288686 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Saaka SA, Mohammed K, K A Pienaah C, Luginaah I. Child malaria vaccine uptake in Ghana: Factors influencing parents’ willingness to allow vaccination of their children under five (5) years. PLoS One. 2024;19(1):e0296934. doi: 10.1371/journal.pone.0296934 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Ajayi MY, Emeto DC. Awareness and acceptability of malaria vaccine among caregivers of under-5 children in Northern Nigeria. Malar J. 2023;22(1):329. doi: 10.1186/s12936-023-04768-z [DOI] [PMC free article] [PubMed] [Google Scholar]
PLOS Glob Public Health. doi: 10.1371/journal.pgph.0004659.r001

Decision Letter 0

Peter James

8 Jul 2025

PGPH-D-25-01040

Knowledge and attitudes of caregivers of under-five children toward the malaria vaccine in the Tiko Health District, Cameroon: A community-based cross-sectional study

PLOS Global Public Health

Dear Dr. Chrisantus Eweh Ukah,

Thank you for submitting your manuscript to PLOS Global Public Health. After careful consideration, we feel that it has merit but does not fully meet PLOS Global Public Health’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

EDITOR: Please address reviewers' comments, including the ones in the attached documents.

Please ensure that your decision is justified on PLOS Global Public Health’s publication criteria  and not, for example, on novelty or perceived impact.

==============================

Please submit your revised manuscript by 22/08/2025. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at globalpubhealth@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pgph/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Peter Bai James, PhD

Academic Editor

PLOS Global Public Health

Journal Requirements:

1. In the online submission form, you indicated that [The dataset supporting the conclusions of this article is available from the corresponding author upon reasonable request.].

All PLOS journals now require all data underlying the findings described in their manuscript to be freely available to other researchers, either

a. In a public repository,

b. Within the manuscript itself, or

c. Uploaded as supplementary information.

This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If your data cannot be made publicly available for ethical or legal reasons (e.g., public availability would compromise patient privacy), please explain your reasons by return email and your exemption request will be escalated to the editor for approval. Your exemption request will be handled independently and will not hold up the peer review process, but will need to be resolved should your manuscript be accepted for publication. One of the Editorial team will then be in touch if there are any issues.

Additional Editor Comments (if provided):

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Does this manuscript meet PLOS Global Public Health’s publication criteria?>

Reviewer #1: No

Reviewer #2: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously?-->?>

Reviewer #1: No

Reviewer #2: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)??>

The PLOS Data policy

Reviewer #1: No

Reviewer #2: No

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

Reviewer #2: Yes

**********

Reviewer #1: Based on my review, the paper requires major revisions before acceptance for publication. The study addresses an important public health problem which is the question of knowledge and attitude or caregivers towards the new malaria vaccine. The potential public health impact of these findings is high, making it crucial that the study is presented with utmost clarity and rigor. I have attached my comments to the authors.

Reviewer #2: Abstract

“A descriptive cross-sectional survey”. Please rephrase as “A cross-sectional survey”

Background

1. Check and correct references in line 60 and 67

2. “Moreover, caregivers' socio-economic 80 status, education level, and exposure to health education initiatives can further affect their understanding and acceptance of new interventions like the malaria vaccine”. Provide a reference

3. While the authors have demonstrated the importance of understanding caregivers knowledge and attitudes toward the malaria vaccine, the research gap that authors are seeking to close, is not clearly established. Has there been similar studies in the study context? Are there similar studies in other contexts in Cameroon or outside Cameroon but from the Sub-Saharan African region? What are the findings of those studies, and the research gap that need to be addressed. Overall, authors should consider delving into the literature of what has been done so far either within the study context or outside of the study context, and then highlight what new thin the current study is adding to the existing literature.

4. There is currently no theoretical underpinning for this study. A study like this must be rooted in in a relevant theoretical framework such as the theory of planned behaviours. While it is not compulsory to use the proposed theory, it is imperative to have the study guided by a relevant theory.

Materials And Methods

1. At line 90, please remove the word “descriptive”. Study design can be cross-sectional or longitudinal but not descriptive. Descriptive is part of the analytical approach.

2. “This study was conducted in some selected health areas of the Tiko Health District”. Please state the selected health areas.

3. The “ETHICAL CONSIDERATIONS” should follow immediately after the “Data Collection” section.

Data Analysis

• A sample size over 400 is large enough for test of association. While the authors did a good job with descriptives, that is too basic/not robust and cannot be used to confirm any hypothesis about knowledge and attitudes towards malaria vaccine. I strongly recommend a more advanced analysis/test of association for statistical significance. From the Tables, I can tell the variable “Aware of malaria vaccine”(outcome measure) is binary, hence a multivariable logistic regression model is more appropriate. See one the pioneering study on child malaria vaccine for guidance: https://doi.org/10.1371/journal.pone.0296934

Results

Kindly remove the “Totals” from Table 1 and 2.

Discussion

The revised version of the manuscript should discuss significant independent variables/predictors form the regression model(s), and discussions should be guided by the theoretical framework of the study as well.

Additional Comments: The study have merit. However, the methodology/analytical approach is currently weak and needs major revision for robustness.

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review? If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: Yes: Suleiman Idris Ahmad

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

Attachment

Submitted filename: REVIEW PLOS.docx

pgph.0004659.s002.docx (18.5KB, docx)
Attachment

Submitted filename: Plos Global Public Health Review comments for authors.docx

pgph.0004659.s003.docx (16.3KB, docx)
PLOS Glob Public Health. doi: 10.1371/journal.pgph.0004659.r003

Decision Letter 1

Helen Howard

27 Nov 2025

PGPH-D-25-01040R1

Knowledge, attitudes and factors associated with the awareness of caregivers of under-five children regarding the malaria vaccine in the Tiko Health District, Cameroon: A community-based cross-sectional study

PLOS Global Public Health

Dear Dr. Ukah,

Thank you for submitting your manuscript to PLOS Global Public Health. After careful consideration, we feel that it has merit but does not fully meet PLOS Global Public Health’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jan 11 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at globalpubhealth@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pgph/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Helen Howard

Staff Editor

PLOS Global Public Health

Journal Requirements:

If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

Additional Editor Comments (if provided):

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

Reviewer #2: (No Response)

**********

publication criteria?>

Reviewer #2: (No Response)

**********

3. Has the statistical analysis been performed appropriately and rigorously?-->?>

Reviewer #2: (No Response)

**********

4. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)??>

The PLOS Data policy

Reviewer #2: (No Response)

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #2: (No Response)

**********

Reviewer #2: Kindly see the attached word document with comments.

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review? If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #2: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

Attachment

Submitted filename: Plos Global Public Health.docx

pgph.0004659.s005.docx (41.8KB, docx)
PLOS Glob Public Health. doi: 10.1371/journal.pgph.0004659.r005

Decision Letter 2

Helen Howard

20 Jan 2026

PGPH-D-25-01040R2

Knowledge, attitudes and factors associated with the awareness of caregivers of under-five children regarding the malaria vaccine in the Tiko Health District, Cameroon: A community-based cross-sectional study

PLOS Global Public Health

Dear Dr. Ukah,

Thank you for submitting your manuscript to PLOS Global Public Health. After careful consideration, we feel that it has merit but does not fully meet PLOS Global Public Health’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Mar 06 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at globalpubhealth@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pgph/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Helen Howard

Staff Editor

PLOS Global Public Health

Journal Requirements:

If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

Additional Editor Comments (if provided):

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

Reviewer #2: All comments have been addressed

Reviewer #3: (No Response)

**********

publication criteria?>

Reviewer #2: Yes

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?-->?>

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)??>

The PLOS Data policy

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #2: Yes

Reviewer #3: Yes

**********

Reviewer #2: The authors have adopted a theoretical framework and also situated discussions with the framework. Thus, I recommend that the manuscript be accepted but wit thorough proofreading from authors prior to publication.

Reviewer #3: Dear authors, thank you for the opportunity to read your work.

While the study's significant results mostly reinforce what is already known about the situation of the malaria vaccine uptake in malaria-endemic regions, I think it is important to report results from multiple data sources and areas.

The following points would improve the manuscript.

Abstract:

1. L16-17, “The introduction of the RTS,S/AS01 (Mosquirix) malaria vaccine offers hope”, you should also mention R21, even though it has not introduced in Cameroon. It should be a general topic regarding malaria vaccines in this introduction part, and it should be comprehensive.

2. L24, you do not need to mention SPSS and its version in the Abstract; it is not so important to be included here.

3. L26, What is the scoring system?

4. L30, I think the statistics of age should be summarized as median and IQR instead of means and SD.

5. You do not need to include the p-value because you included the 95% CI; it can reduce the word count of the abstract.

6. L39-41, These are the results of your analysis, and it is a repetition of what you stated above. Instead, you need to write a conclusion from your study here.

Materials and methods:

7. L126-127: The date information was repeated.

8. L133-134: What is the proportion? I guess it is the proportion of caregivers' awareness of malaria vaccine or something? It must be the primary interest of the study.

9. L140: You need to explain why it was made up to 410.

10. L178: You wrote four distinct sections, but it seems there are only three sections.

11. L238: SPSS should be spelled out when it appears first, such as L235.

12. L242: There are no pie charts, and I do not even think you need pie charts. The table is enough.

13. L248: Can you explain why you set the cutoff of 60%?

Results:

14. L258: Is “under children” a typo?

15. Table 1: Category for number of children should be >4 instead of 4+. The category for household income should be >100,000 instead of 100000+. And what is the currency, and how much is it in USD?

16. Table 2: For the doses of malaria vaccine, because children were 0-5 years, I guess some small children have not reached the age of Dose 4 yet. Did you consider such age eligibility for each child and each dose?

17. I don’t think Figure 1 is necessary. It can be a table.

18. L279-281, the statements of “With respect to the overall knowledge of caregivers on the malaria vaccine, 60% of the maximum obtainable score was used as the cut off point for good knowledge. A total of seven questions were asked with a maximum obtainable score of 7.” Is repetition.

Discussion:

19. L338-339, Not clear how guided by the HBM. You should mention the details of the model in the Methods section.

20. L354-355, I do not think the difference between 30% and 40% is big enough, especially since you did not include confidence intervals at all in these figures.

21. I think the sample size is not enough for the logistic regression. For example, the factors of female, higher education, Muslim, and accessible health services seemed to have a higher tendency to be aware of malaria vaccines, according to Table 4. You should mention these things, and also, the sample size should be mentioned as one of the limitations of your study.

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review? If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #2: No

Reviewer #3: Yes: Yura K Ko

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

After uploading your figures to PLOS’s NAAS tool - https://ngplosjournals.pagemajik.ai/artanalysis, NAAS will process the files provided and display the results in the "Uploaded Files" section of the page as the processing is complete. If the uploaded figures meet our requirements (or NAAS is able to fix the files to meet our requirements), the figure will be marked as "fixed" above. If NAAS is unable to fix the files, a red "failed" label will appear above. When NAAS has confirmed that the figure files meet our requirements, please download the file via the download option, and include these NAAS processed figure files when submitting your revised manuscript.

Attachment

Submitted filename: comments.docx

pgph.0004659.s007.docx (16.9KB, docx)
PLOS Glob Public Health. doi: 10.1371/journal.pgph.0004659.r007

Decision Letter 3

Ruth Ashton

10 Feb 2026

PGPH-D-25-01040R3

Knowledge, attitudes and factors associated with the awareness of caregivers of under-five children regarding the malaria vaccine in the Tiko Health District, Cameroon: A community-based cross-sectional study

PLOS Global Public Health

Dear Dr. Ukah,

Thank you for submitting your manuscript to PLOS Global Public Health. After careful consideration, we feel that it has merit but does not fully meet PLOS Global Public Health’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

All previous reviewer comments have been addressed, however I have one final recommendation from an editorial perspective to enhance interpretation of your results. Please consider including a sentence or two in the introduction section explaining when RTS,S was approved for use in Cameroon, and when the vaccine was first available to children within the study district. This information will help to contextualise the reported findings, and make it easier for readers to compare these levels of knowledge and awareness across other settings as vaccine scale-up continues.

Please submit your revised manuscript by Mar 12 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at globalpubhealth@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pgph/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A letter that responds to each point raised by the editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

We look forward to receiving your revised manuscript.

Kind regards,

Ruth Ashton, Ph.D.

Academic Editor

PLOS Global Public Health

Journal Requirements:

If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments (if provided):

Please consider including a sentence or two in the introduction section explaining when RTS,S was approved for use in Cameroon, and when the vaccine was first available to children within the study district. This information will help to contextualise the reported findings, and make it easier for readers to compare these levels of knowledge and awareness across other settings as vaccine scale-up continues.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

Reviewer #3: All comments have been addressed

**********

publication criteria?>

Reviewer #3: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?-->?>

Reviewer #3: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available (please refer to the Data Availability Statement at the start of the manuscript PDF file)??>

The PLOS Data policy

Reviewer #3: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #3: Yes

**********

Reviewer #3: I appreciate the authors’ careful and comprehensive responses, and I consider that all comments have been adequately addressed.

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

Do you want your identity to be public for this peer review? If you choose “no”, your identity will remain anonymous but your review may still be made public.

For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #3: Yes: Yura K Ko

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

PLOS Glob Public Health. doi: 10.1371/journal.pgph.0004659.r009

Decision Letter 4

Ruth Ashton

13 Feb 2026

Knowledge, attitudes and factors associated with the awareness of caregivers of under-five children regarding the malaria vaccine in the Tiko Health District, Cameroon: A community-based cross-sectional study

PGPH-D-25-01040R4

Dear Mr Ukah,

We are pleased to inform you that your manuscript 'Knowledge, attitudes and factors associated with the awareness of caregivers of under-five children regarding the malaria vaccine in the Tiko Health District, Cameroon: A community-based cross-sectional study' has been provisionally accepted for publication in PLOS Global Public Health.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they'll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact globalpubhealth@plos.org.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Global Public Health.

Best regards,

Ruth Ashton, Ph.D.

Academic Editor

PLOS Global Public Health

***********************************************************

Reviewer Comments (if any, and for reference):

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    S1 Data. Anonymized dataset used in the study.

    (XLSX)

    pgph.0004659.s001.xlsx (79KB, xlsx)
    Attachment

    Submitted filename: REVIEW PLOS.docx

    pgph.0004659.s002.docx (18.5KB, docx)
    Attachment

    Submitted filename: Plos Global Public Health Review comments for authors.docx

    pgph.0004659.s003.docx (16.3KB, docx)
    Attachment

    Submitted filename: RESPONSE TO REVIEWER COMMENTS_KAF1.docx

    pgph.0004659.s006.docx (22.8KB, docx)
    Attachment

    Submitted filename: Plos Global Public Health.docx

    pgph.0004659.s005.docx (41.8KB, docx)
    Attachment

    Submitted filename: Response to Reviewer Comments.docx

    pgph.0004659.s008.docx (16.9KB, docx)
    Attachment

    Submitted filename: comments.docx

    pgph.0004659.s007.docx (16.9KB, docx)
    Attachment

    Submitted filename: RESPONSE TO REVIEWERS F.docx

    pgph.0004659.s009.docx (18.9KB, docx)
    Attachment

    Submitted filename: Response to editor.docx

    pgph.0004659.s010.docx (13.3KB, docx)

    Data Availability Statement

    All relevant data are within the paper and its Supporting Information files. The de-identified dataset underlying the findings of this study has been provided as a Supporting Information file in Excel format.


    Articles from PLOS Global Public Health are provided here courtesy of PLOS

    RESOURCES